BodiGuide Inc. Announces Technology Breakthrough; Revolutionary New Device Continuously Measures Edema
07. Dezember 2022 09:00 ET
|
BodiGuide
BELLEVUE, Wash., Dec. 07, 2022 (GLOBE NEWSWIRE) -- BodiGuide Inc. today announced a new technology capable of continuously measuring leg edema and quantifying fluid retention has been developed by...
Global Hereditary Angioedema Market Report to 2030 - by Drug Class, Route of Administration, Distribution Channel and Region
31. August 2022 07:03 ET
|
Research and Markets
Dublin, Aug. 31, 2022 (GLOBE NEWSWIRE) -- The "Hereditary Angioedema Market - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030" report has been added to ResearchAndMarkets.com's offering....
Insights on the Sodium Hyaluronate-based Products Global Market to 2030 - Featuring Allergan, Cadila Pharmaceuticals and Galderma Among Others
03. Juni 2022 07:03 ET
|
Research and Markets
Dublin, June 03, 2022 (GLOBE NEWSWIRE) -- The "Sodium Hyaluronate-based Products Market Share, Size, Trends, Industry Analysis Report, By Type; By Application; By Region; Segment Forecast, 2022 -...
Insights on the Lymphedema Treatment Global Market to 2028 - Featuring Bio Compression, Tactile Medical and Smith & Nephew Among Others
01. März 2022 07:13 ET
|
Research and Markets
Dublin, March 01, 2022 (GLOBE NEWSWIRE) -- The "Lymphedema Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Condition Type, Treatment Type, and End-User" report has been...
Endonovo Therapeutics Expands SofPulse® Sales to Plastic Surgery Centers
30. Januar 2020 07:00 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Jan. 30, 2020 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") today announced sales of SofPulse® units to multiple Plastic Surgery...
Endonovo Therapeutics Provides Corporate Update
26. April 2019 08:00 ET
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA, April 26, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive Electroceutical™ therapeutic...
Endonovo Expands SofPulse Commercialization
13. Dezember 2018 09:20 ET
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA, Dec. 13, 2018 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive Electroceutical™ therapies,...
Endonovo Therapeutics Announces Enrollment of First Patient in Clinical Study at the University of New Mexico for Treating Traumatic Brain Injury Using Its Electroceutical™ Therapy
14. Juni 2018 08:30 ET
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA, June 14, 2018 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of Electroceutical™ Therapies, today...